Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture
- 1 August 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (16) , 2105-2108
- https://doi.org/10.1016/s0960-894x(97)00368-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- GanciclovirDrugs, 1994
- FoscarnetDrugs, 1994
- Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frameVirology, 1992
- Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastaseJournal of Medicinal Chemistry, 1990
- The Products of Herpes Simplex Virus Type 1 Gene UL26 which Are Involved in DNA Packaging Are Strongly Associated with Empty but Not with Full CapsidsJournal of General Virology, 1988
- Crystal structures of the complex of porcine pancreatic elastase with two valine-derived benzoxazinone inhibitorsJournal of Molecular Biology, 1987
- Mechanism for slow-binding inhibition of human leukocyte elastase by valine-derived benzoxazinonesBiochemistry, 1987
- Design of alternate substrate inhibitors of serine proteases. Synergistic use of alkyl substitution to impede enzyme-catalyzed deacylationJournal of Medicinal Chemistry, 1987
- Inhibition of serine proteases by benzoxazinones: effects of electron withdrawal and 5-substitutionBiochemical and Biophysical Research Communications, 1986
- New class of serine protease inactivators based on isatoic anhydrideJournal of the American Chemical Society, 1982